Peptinovo Biopharma

Ann Arbor, MI · Founded 2018 · Privately Held (backing)

Operator of a drug delivery company intended to improve cancer survival. Peptinovo Biopharma is based in Ann Arbor, MI and was founded in 2018. It was valued at $23.3 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $1.3 million across 2 recorded rounds; the latest was a $1.3 million seed round in Sep 2024.

PMV mark · valuation
$23.3M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$1.3M
Last round
Seed Round
Sep 2024
What is Peptinovo Biopharma worth?
$23.3MPrivateMarketView mark · Oct 2026

Valued at $23.3M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of Peptinovo Biopharma with a free account
  • ·Watch Peptinovo Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Peptinovo Biopharma funding history

2 rounds
DateRoundRaisedPost-money
Sep 2024Seed Round$1.3M▮
Jun 2021Seed Round$955K▮
Unlock post-money valuations

Membership and data by Private Market View

Peptinovo Biopharma valuation

Peptinovo Biopharma was valued at $23.3 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Peptinovo Biopharma raised?

Peptinovo Biopharma has raised $1.3 million across 2 recorded rounds since 2021. The largest was a $955,000 seed round in Jun 2021; the most recent was a $1.3 million seed round in Sep 2024.

Peptinovo Biopharma has filed 3 Form Ds with the SEC since 2021, most recently in Dec 2024 ($1.3 million sold to 12 investors).

How Peptinovo Biopharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Peptinovo Biopharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Peptinovo Biopharma

What is Peptinovo Biopharma worth?
Peptinovo Biopharma is valued at $23.3M as of Oct 2026. Valued at $23.3M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Peptinovo Biopharma raised?
Peptinovo Biopharma has raised $1.3M in total funding across 2 recorded rounds.
When did Peptinovo Biopharma last raise?
Peptinovo Biopharma last raised in Sep 2024 (Seed Round), raising $1.3M.